Alpy F, Stoeckel M E, Dierich A, Escola J M, Wendling C, Chenard M P, Vanier M T, Gruenberg J, Tomasetto C, Rio M C
Institut de Génétique et de Biologie Moléculaire et Cellulaire, UPR 6520 CNRS/U184 INSERM/Université Louis Pasteur, BP 163, 67404 Illkirch, C.U. de Strasbourg, France.
J Biol Chem. 2001 Feb 9;276(6):4261-9. doi: 10.1074/jbc.M006279200. Epub 2000 Oct 26.
MLN64 is a transmembrane protein that shares homology with the cholesterol binding domain (START domain) of the steroidogenic acute regulatory protein. The steroidogenic acute regulatory protein is located in the inner membrane of mitochondria, where it facilitates cholesterol import into the mitochondria. Crystallographic analysis showed that the START domain of MLN64 is a cholesterol-binding domain. The present work was undertaken to determine which step of the intracellular cholesterol pathway MLN64 participates in. Using immunocytofluorescence, MLN64 colocalizes with LBPA, a lipid found specifically in late endosomes. Electron microscopy indicates that MLN64 is restricted to the limiting membrane of late endosomes. Microinjection or endocytosis of specific antibodies shows that the START domain of MLN64 is cytoplasmic. Deletion and mutagenesis experiments demonstrate that the amino-terminal part of MLN64 is responsible for its addressing. Although this domain does not contain conventional dileucine- or tyrosine-based targeting signals, we show that a dileucine motif (Leu(66)-Leu(67)) and a tyrosine residue (Tyr(89)) are critical for the targeting or the proper folding of the molecule. Finally, MLN64 colocalizes with cholesterol and Niemann Pick C1 protein in late endosomes. However, complementation assays show that MLN64 is not involved in the Niemann Pick C2 disease which, results in cholesterol lysosomal accumulation. Together, our results show that MLN64 plays a role at the surface of the late endosomes, where it might shuttle cholesterol from the limiting membrane to cytoplasmic acceptor(s).
MLN64是一种跨膜蛋白,与类固醇生成急性调节蛋白的胆固醇结合结构域(START结构域)具有同源性。类固醇生成急性调节蛋白位于线粒体内膜,在那里它促进胆固醇进入线粒体。晶体学分析表明,MLN64的START结构域是一个胆固醇结合结构域。开展本研究以确定MLN64参与细胞内胆固醇途径的哪一步。利用免疫细胞荧光技术,MLN64与LBPA共定位,LBPA是一种专门存在于晚期内体中的脂质。电子显微镜显示MLN64局限于晚期内体的界膜。特异性抗体的显微注射或内吞作用表明,MLN64的START结构域位于细胞质中。缺失和诱变实验表明,MLN64的氨基末端部分负责其靶向定位。尽管该结构域不包含传统的基于双亮氨酸或酪氨酸的靶向信号,但我们表明双亮氨酸基序(Leu(66)-Leu(67))和酪氨酸残基(Tyr(89))对于分子的靶向定位或正确折叠至关重要。最后,MLN64在晚期内体中与胆固醇和尼曼-皮克C1蛋白共定位。然而,互补分析表明,MLN64不参与导致胆固醇溶酶体蓄积的尼曼-皮克C2病。总之,我们的结果表明,MLN64在晚期内体表面发挥作用,在那里它可能将胆固醇从界膜转运至细胞质受体。